Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. I won't rehash Pfizer's pandemic journey too much. The company developed and sold a vaccine (Comirnaty) ...

Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Markets expect ...

A high dividend yield can be enticing, but it can also raise flags for income investors. Pfizer's falling valuation has pushed its yield up to well over 7%, which warrants a closer look.

Consider pharmaceutical giant Pfizer (NYSE: PFE). Its dividend yield is around 7.5% right now ... Where to invest $1,000 right now? Our analyst team just revealed what they believe are the ...

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying ...